TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Elixinol Wellness ( (AU:EXL) ) is now available.
Elixinol Wellness has announced the resignation of David Fenlon as Chair of the Board, with Gavin Evans stepping in as the new Independent Non-Executive Chair. Evans, who has a strong background in building profitable wellness businesses, has been a strategic adviser to Elixinol and is expected to drive the company’s transformation agenda towards profitability. His leadership is anticipated to enhance operational discipline and growth, benefiting stakeholders and supporting the company’s strategic goals.
The most recent analyst rating on (AU:EXL) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Elixinol Wellness stock, see the AU:EXL Stock Forecast page.
More about Elixinol Wellness
Elixinol Wellness Limited (ASX: EXL) is a global health and wellness company that innovates, markets, and sells hemp and other plant-derived food, skincare, and nutraceutical products. Operating in Australia and the USA, the company manages a vertically integrated business across human nutrition, human wellness, pet wellness, and superfood ingredients. Their products are distributed through brands like Hemp Foods Australia, The Healthy Chef, and others via grocery, wholesale, and e-commerce channels.
Average Trading Volume: 566,148
Technical Sentiment Signal: Sell
Current Market Cap: A$4.14M
See more data about EXL stock on TipRanks’ Stock Analysis page.